Apr 6, 2009 - Santarus, Inc., a specialty pharmaceutical company, today announced that the U.S. FDA has accepted for filing the company's New Drug Application for a new tablet formulation to add to its ZEGERID family of branded prescription pharmaceutical products.
the details can be read here.
No comments:
Post a Comment